Search results for "Cardiovascular Disease"
Exercise a fitting path to improved health
Some physicians tout successes in getting patients moving more by suggesting incremental changes in their activity levels, and also by highlighting the more immediately visible payoffs.
https://immattersacp.org/archives/2021/04/exercise-a-fitting-path-to-improved-health.htm
1 Apr 2021
Total knee replacement cost-effective for end-stage osteoarthritis even in severe obesity
A modeling study analyzed the long-term effects and costs of total knee replacement for patients who were ages 50 years or older and had end-stage knee osteoarthritis and a body mass index of 40 kg/m2 or greater.
https://immattersacp.org/weekly/archives/2021/03/23/4.htm
23 Mar 2021
Subclinical hypothyroidism prompts personalized decisions
For diagnosing and managing subclinical hypothyroidism, clinical context such as age and symptoms matter, even in the face of an incomplete understanding of the condition.
https://immattersacp.org/archives/2021/02/subclinical-hypothyroidism-prompts-personalized-decisions.htm
1 Feb 2021
New research looks at COVID-19 quarantine length in asymptomatic contacts, convalescent plasma for mild disease, related health issues
Seven-day quarantine may be sufficient for contacts without symptoms, older adults with mild disease may benefit from convalescent plasma, and cardiovascular deaths increased during the early stage of the pandemic.
https://immattersacp.org/weekly/archives/2021/01/12/3.htm
12 Jan 2021
Getting patients to ‘yes' on COVID-19 vaccines
Experts believe practicing physicians are well positioned to take a lead role combating one of the biggest anticipated obstacles to widespread vaccination: vaccine hesitancy.
https://immattersacp.org/archives/2021/01/getting-patients-to-yes-on-covid-19-vaccines.htm
1 Jan 2021
High-dose flu vaccine may not be more effective than standard dose in patients with high-risk cardiovascular disease
An industry-funded randomized trial in the U.S. and Canada found no significant difference between a high-dose group versus a standard-dose group in the time to first occurrence of all-cause death or cardiopulmonary hospitalization during three flu seasons.
https://immattersacp.org/weekly/archives/2020/12/15/5.htm
15 Dec 2020
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
Studies of LDL levels, therapies support treatment of those older than age 70
A retrospective study found the association between low-density lipoprotein (LDL) cholesterol levels and cardiovascular events to increase with age, while a meta-analysis highlighted the benefits of statins and other lipid-lowering therapies in older patients.
https://immattersacp.org/weekly/archives/2020/11/17/4.htm
17 Nov 2020
Guideline released on adults with Down syndrome, while study looks at COVID-19 risk
A recent clinical guideline calls for screening patients with Down syndrome for Alzheimer-type dementia starting at age 40 years and diabetes starting at age 30 years. Down syndrome is also associated with high risk for death from COVID-19, a new study found.
https://immattersacp.org/weekly/archives/2020/10/27/2.htm
27 Oct 2020
Easing screens for intimate partner violence
Internists can be leaders in addressing intimate partner violence, a problem for which effective screening tools and interventions are available.
https://immattersacp.org/archives/2020/10/easing-screens-for-intimate-partner-violence.htm
1 Oct 2020